Abstract
The nitrogen-containing compound, colchicine, has been used medicinally for millennia. It was first isolated from the plant Colchicum autumnale, by the French chemists P.S. Pelletier and J. Caventon. Today, colchicine is primarily used for the treatment of gout and auto-inflammatory diseases, such as familial Mediterranean fever (FMF), but it has been also investigated for its therapeutic utility in a number of respiratory diseases such as asthma, chonic obstructive pulmonary disease and idiopathic pulmonary fibrosis. While colchicine has shown some promise as an adjuvant to corticosteroid treatment, the benefit of the drug remains to be elucidated. The lack of serious adverse effects of oral colchicine at therapeutic levels should ease the design of more specific trials.
Keywords: Asthma, chronic obstructive pulmonary diease, colchicine, idiopathic pulmonary fibrosis.
Current Respiratory Medicine Reviews
Title:The Use of Colchicine in Respiratory Diseases
Volume: 9 Issue: 5
Author(s): Ori-Michael J. Benhamou, Shahar Geva, Miriam Jacobs, Jonathan Drew, Maor Waldman and Or Kalchiem-Dekel
Affiliation:
Keywords: Asthma, chronic obstructive pulmonary diease, colchicine, idiopathic pulmonary fibrosis.
Abstract: The nitrogen-containing compound, colchicine, has been used medicinally for millennia. It was first isolated from the plant Colchicum autumnale, by the French chemists P.S. Pelletier and J. Caventon. Today, colchicine is primarily used for the treatment of gout and auto-inflammatory diseases, such as familial Mediterranean fever (FMF), but it has been also investigated for its therapeutic utility in a number of respiratory diseases such as asthma, chonic obstructive pulmonary disease and idiopathic pulmonary fibrosis. While colchicine has shown some promise as an adjuvant to corticosteroid treatment, the benefit of the drug remains to be elucidated. The lack of serious adverse effects of oral colchicine at therapeutic levels should ease the design of more specific trials.
Export Options
About this article
Cite this article as:
Benhamou J. Ori-Michael, Geva Shahar, Jacobs Miriam, Drew Jonathan, Waldman Maor and Kalchiem-Dekel Or, The Use of Colchicine in Respiratory Diseases, Current Respiratory Medicine Reviews 2013; 9 (5) . https://dx.doi.org/10.2174/1573398X10666140526235154
DOI https://dx.doi.org/10.2174/1573398X10666140526235154 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomarker Metabolite Signatures Pave the Way for Electronic-nose Applications in Early Clinical Disease Diagnoses
Current Metabolomics Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry Pathophysiology of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
Current Cardiology Reviews Biological Relevance of Lysophospholipids and Green Solutions for Their Synthesis
Current Organic Chemistry Immune Cell-derived Vesicles: Modulators and Mediators of Inflammation
Current Pharmaceutical Design Optimization of Site Targeted Zolmitriptan Delivery Using Polyox N12K and Methacrylic Acid
Current Drug Therapy Melanin-Concentrating Hormone Receptor 1 Antagonists: A New Perspective for the Pharmacologic Treatment of Obesity
Current Medicinal Chemistry Inflammatory Cytokines, Growth Factors, and Depression
Current Pharmaceutical Design Start Small and Stay Small: Minimizing Attrition in the Clinic with a Focus on CNS Therapeutics
Current Topics in Medicinal Chemistry Vcsa1 Gene Peptides for the Treatment of Inflammatory and Allergic Reactions
Recent Patents on Inflammation & Allergy Drug Discovery Use of Glucocorticoids in Pregnancy
Current Pharmaceutical Design An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists
Current Medicinal Chemistry Disintegrins from Snake Venoms and their Applications in Cancer Research and Therapy
Current Protein & Peptide Science α-Fluorinated Ethers as “Exotic” Entity in Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Putative Immune Regulatory Role of Statins
Current Immunology Reviews (Discontinued) Molecular Recognition of Tachykinin Receptor Selective Agonists: Insights from Structural Studies
Mini-Reviews in Medicinal Chemistry Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Allergic Contact Dermatitis: Novel Mechanisms and Therapeutic Perspectives
Current Drug Metabolism Immunomodulatory Effects of Medicinal Plants used for Vitiligo in Traditional Persian Medicine
Current Drug Discovery Technologies